Microarray manufacturer Affymetrix of Santa Clara, Calif., http://www.affymetrix.com and laser-capture microdissection company Arcturus of Mountain View, Calif. http://www.arctur.com, have teamed up, offering the GeneChip X3P array and the Paradise™ reagent system, respectively, to enable gene expression analysis of archived formalin-fixed, paraffin-embedded (FFPE) samples. "These samples represent a treasure trove for genomic discovery efforts, because they generally are associated with known clinical outcomes," says Peter Dansky, formerly vice president of marketing at Arcturus.

Extracting high-quality mRNA suitable for microarray analyses from FFPE samples was not feasible in the past, says Renata Coudry, a research pathologist in the chemoprevention program at Fox Chase Cancer Center in Philadelphia. Previously, Coudry and colleagues could characterize only a small subset of molecular markers in colitis-associated colorectal dysplasias; they now can analyze the expression of a vast number of genes.

Since these samples tend to yield shorter RNAs, the X3P's probes contain an extreme 3'...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Join for free todayAlready a member?Login Here